Maxion Therapeutics News and Activities

Acquisition, funding and merger involving Maxion Therapeutics.

• Maxion Therapeutics has just announced a $72 Million fundraising (posted on April 3 2025).

View the org chart displaying its 20 main executives

Most searched biographies at Maxion Therapeutics

• Arndt Schottelius, Chief Executive Officer
• Sohaib Mir, Non-Executive Director
• Lucy Jones, Non-Executive Director

Popular executive movements at Maxion Therapeutics

• Joel Edwards has joined the company as Chief Business Officer  (posted on October 2 2025).

Create your alert
to follow the executive moves at Maxion Therapeutics.

Maxion Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Maxion Therapeutics

• Maxion Therapeutics
• Maxion Therapeutics
• Maxion Therapeutics
• Maxion Therapeutics
• Maxion Therapeutics

Social media about Maxion Therapeutics

• Maxion Therapeutics on Wikipedia, Google News & Yahoo Finance
• Maxion Therapeutics on LinkedIn, X (Twitter) & YouTube